Florian Eichler, MD
Neurology · Boston, MANPI 1487631412
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (51.8%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Acadia Pharmaceuticals Inc at 33.4% of the total. 2025 is the largest year on record at $16,044, 2.8 times the $5,760 reported in 2021.
Across 13 payments — averaging $2136.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acadia Pharmaceuticals Inc$9K
- Sanofi US Services Inc.$6K
- Sanofi$5K
- Alnylam Pharmaceuticals Inc.$3K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Mirum Pharmaceuticals, Inc.$2K
Across 86 payments — averaging $13,230 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genetix Biotherapeutics Inc$614K
- AbbVie$323K
- Ionis Pharmaceuticals, Inc.$96K
- Sanofi US Services Inc.$83K
- Sanofi$22K
What the payments were for
- Consulting fees$14,38852%
- Speaking & faculty fees$13,23848%
- Food & beverage$1501%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acadia Pharmaceuticals Inc | 4 | $9,288 |
| Sanofi US Services Inc. | 2 | $5,732 |
| Sanofi | 3 | $5,221 |
| Alnylam Pharmaceuticals Inc. | 1 | $3,360 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $2,400 |
| Mirum Pharmaceuticals, Inc. | 2 | $1,775 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$27,775 in reported general payments places this provider in the 85th percentile of 761 neurology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Boston
- Christopher WrightBoston$2.5M
- Thomas ScammellBoston$617K
- Alfred SandrockBoston$490K
- Pushpa NarayanaswamiBoston$420K
- Roy FreemanBoston$390K
- Michael LevyBoston$387K
- Leeann BurtonBoston$325K
- Ilena GeorgeBoston$316K
- Andrew BudsonBoston$304K
- Denis BalabanBoston$297K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.